Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced positive, ...
Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three and ...
Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million Q3 Galleri Tests Sold Grew 39% Year-Over-Year to More Than 45,000 Galleri PMA Submission ...
IZEA will hold a conference call to discuss its third quarter 2025 results on Wednesday, November 12, 2025, at 5:00 p.m. EST.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback